TB
TPG Biotech
Venture CapitalActiveTPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry.
San Francisco, United StatesFounded 1996
60
Investments
9
Exits
$1.2B
AUM
15.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for TPG Biotech.
Investment Thesis & Strategy
TPG Biotech invests in growth-stage biotechnology companies, leveraging its expertise to provide capital and strategic guidance to accelerate innovation and market leadership.
Notable Exits
CompanyTypeYearValue / Acquirer
Turning Point TherapeuticsAcquisition2022$4.1B
TesaroAcquisition2019$5.1B
MedivationAcquisition2016$14B
Kura OncologyIPO2014—
Portola PharmaceuticalsIPO2013—
ChimerixIPO2013—
EpizymeIPO2013—
Intercept PharmaceuticalsIPO2012—
Acadia PharmaceuticalsIPO2004—
Frequently Asked Questions
TPG Biotech focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals